Skip to main content
. 2017 Apr 17;8(25):41227–41241. doi: 10.18632/oncotarget.17167

Figure 6. AKT1 and PTEN gene expression in human breast cancers before and after 16 weeks of doxorubicin treatment.

Figure 6

(A) Box plots of gene expression of PTEN and AKT1 normalized to RPLP2 in human breast cancer samples, before and after 16 weeks of doxorubicin treatment, from patients in the doxorubicin trial. (B) Box plots from the same patient cohort as in (A), but depicted separately for estrogen receptor (ER) positive and negative breast cancers. *p<0.05